Company intelligence / Profile preview

Xiogenix

Muskego, Wisconsin, United Statesxiogenix.com ↗

Ownership: Private
Employees: ~22
Development stage: Commercial

Overview

Xiogenix develops and commercializes advanced automation equipment for downstream processing in tissue banking as well as cell and gene therapy manufacturing. Their flagship ARES™ X20+ system supports fill & finish operations under cGMP conditions. The company collaborates with bioscience industry leaders to optimize workflows from R&D through full-scale production. No clinical results apply since they do not develop drugs.

Modalities: DeviceEquipment for cell therapy and gene therapy processingAutomation equipment for tissue banking and regenerative medicine
Industry: Therapeutic Medical Devices

Partnerships

Collaborates with leading companies in biosciences/regenerative medicine sectors to co-develop custom automation solutions

Beyond the preview

Go deeper on Xiogenix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiogenix.

Explore the full profile